These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33287230)

  • 1. Epigenetic Targets for Oligonucleotide Therapies of Pulmonary Arterial Hypertension.
    Gerthoffer W
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the Methylation and Expression Levels of the BMPR2 Gene by SIN3a as a Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension.
    Bisserier M; Mathiyalagan P; Zhang S; Elmastour F; Dorfmüller P; Humbert M; David G; Tarzami S; Weber T; Perros F; Sassi Y; Sahoo S; Hadri L
    Circulation; 2021 Jul; 144(1):52-73. PubMed ID: 34078089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Inheritance Underlying Pulmonary Arterial Hypertension.
    Napoli C; Benincasa G; Loscalzo J
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):653-664. PubMed ID: 30727752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic targets for novel therapies of lung diseases.
    Comer BS; Ba M; Singer CA; Gerthoffer WT
    Pharmacol Ther; 2015 Mar; 147():91-110. PubMed ID: 25448041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension.
    Han Y; Ali MK; Dua K; Spiekerkoetter E; Mao Y
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Mechanisms as Emerging Therapeutic Targets and Microfluidic Chips Application in Pulmonary Arterial Hypertension.
    Ho L; Hossen N; Nguyen T; Vo A; Ahsan F
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment.
    Wołowiec Ł; Mędlewska M; Osiak J; Wołowiec A; Grześk E; Jaśniak A; Grześk G
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development.
    Dave J; Jagana V; Janostiak R; Bisserier M
    J Transl Med; 2023 Jul; 21(1):477. PubMed ID: 37461108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension.
    Luna RCP; de Oliveira Y; Lisboa JVC; Chaves TR; de Araújo TAM; de Sousa EE; Miranda Neto M; Pirola L; Braga VA; de Brito Alves JL
    Braz J Med Biol Res; 2018 Oct; 51(12):e7437. PubMed ID: 30365723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension.
    Kim JD; Lee A; Choi J; Park Y; Kang H; Chang W; Lee MS; Kim J
    Exp Mol Med; 2015 Jul; 47(7):e175. PubMed ID: 26228095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension.
    He YZ; Wang YX; Ma JS; Li RN; Wang J; Lian TY; Zhou YP; Yang HP; Sun K; Jing ZC
    Vascul Pharmacol; 2023 Dec; 153():107216. PubMed ID: 37699495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the genome: challenges and potential for epigenetics-driven therapeutic approaches in pulmonary arterial hypertension.
    Hsu JY; Major JL; Riching AS; Sen R; Pires da Silva J; Bagchi RA
    Biochem Cell Biol; 2020 Dec; 98(6):631-646. PubMed ID: 32706995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Regulation of Pulmonary Arterial Hypertension-Induced Vascular and Right Ventricular Remodeling: New Opportunities?
    Kocken JMM; da Costa Martins PA
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertension.
    Ranasinghe ADCU; Schwarz MA
    Biochem Pharmacol; 2022 Oct; 204():115245. PubMed ID: 36096239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-tracheal gene delivery of aerosolized SERCA2a to the lung suppresses ventricular arrhythmias in a model of pulmonary arterial hypertension.
    Strauss B; Sassi Y; Bueno-Beti C; Ilkan Z; Raad N; Cacheux M; Bisserier M; Turnbull IC; Kohlbrenner E; Hajjar RJ; Hadri L; Akar FG
    J Mol Cell Cardiol; 2019 Feb; 127():20-30. PubMed ID: 30502350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M; Gomez-Puerto MC; Ten Dijke P
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Mutations and Decreased Expression of the Epigenetic Regulator
    Potus F; Pauciulo MW; Cook EK; Zhu N; Hsieh A; Welch CL; Shen Y; Tian L; Lima P; Mewburn J; D'Arsigny CL; Lutz KA; Coleman AW; Damico R; Snetsinger B; Martin AY; Hassoun PM; Nichols WC; Chung WK; Rauh MJ; Archer SL
    Circulation; 2020 Jun; 141(24):1986-2000. PubMed ID: 32192357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical effects of epigenetic regulation in pulmonary arterial hypertension.
    Chen D; Gao W; Wang S; Ni B; Gao Y
    Cell Mol Life Sci; 2017 Oct; 74(20):3789-3808. PubMed ID: 28573430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-145-targeted drug and its preventive effect on pulmonary arterial hypertension (patent WO2012153135 A1).
    Ogorodnikova N; Arenz C
    Expert Opin Ther Pat; 2015 Jun; 25(6):723-7. PubMed ID: 25787302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.